• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryCurrent TOCInstructions for authors
J Neurol Neurosurg Psychiatry. Jul 2001; 71(1): 81–87.
PMCID: PMC1737486

Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis


Acquired cerebellar ataxia has been described with hypothyroidism, and is typically reversible by thyroid hormone replacement therapy. The cerebellar dysfunction has been attributed to metabolic and physiological effects of the endocrine disorder. In a few patients, however, ataxia has persisted despite thyroid replacement therapy. Other mechanisms may be involved in ataxia associated with thyroid disorders.
OBJECTIVE—To document progressive non-familial adult onset cerebellar degeneration (PNACD) occurring in six patients with raised antithyroid antibodies (Hashimoto's/autoimmune thyroiditis), and other autoimmune manifestations, in the absence of hypothyroidism; and to document the independence of the cerebellar disorder from the endocrine dysfunction.
METHODS—A case study of six patients with PNACD reviewing the clinical course and relation to endocrine and autoimmune status.
RESULTS—All six patients were euthyroid when they developed their symptoms; had raised antithyroid antibodies consistent with Hashimoto's autoimmune thyroiditis; and had strong personal or family histories of organ specific autoimmune diatheses. Brain MRI disclosed atrophy of the cerebellar vermis in four patients and olivopontocerebellar atrophy in two. Other possible causes of cerebellar degeneration were excluded. De novo treatment (two patients) or continued treatment (three patients) with L-thyroxine did not modify the progression of the ataxia.
CONCLUSIONS—Cerebellar degeneration in these patients with raised antithyroid antibodies may be immune mediated. The presence of antithyroid antibodies may signal or cause the autoimmune process producing cerebellar degeneration. "Hashimoto's associated ataxia" seems to represent a recognisable and not uncommon condition; a trial of immunomodulating therapy should be considered in these patients.

Full Text

The Full Text of this article is available as a PDF (195K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997 Aug;120(Pt 8):1279–1300. [PubMed]
  • Barnard RO, Campbell MJ, McDonald WI. Pathological findings in a case of hypothyroidism with ataxia. J Neurol Neurosurg Psychiatry. 1971 Dec;34(6):755–760. [PMC free article] [PubMed]
  • Cremer GM, Goldstein NP, Paris J. Myxedema and ataxia. Neurology. 1969 Jan;19(1):37–46. [PubMed]
  • Erkulvrawatr S. Gait ataxia in hypothyroidism. J Ky Med Assoc. 1977 Dec;75(12):581–582. [PubMed]
  • Gentilini M, Palmieri M. Atassia cerebellare mixedematosa. Descrizione di un caso. Riv Patol Nerv Ment. 1984 Mar-Apr;105(2):75–80. [PubMed]
  • Hammar CH, Regli F. Zerebellare Ataxie infolge Hypothyreose beim Erwachsenen. Dtsch Med Wochenschr. 1975 Jul 11;100(28):1504–1506. [PubMed]
  • JELLINEK EH, KELLY RE. Cerebellar syndrome in myxoedema. Lancet. 1960 Jul 30;2(7144):225–227. [PubMed]
  • Takayanagi K, Satoh A, Yoshimura T, Hazama R, Ide Y, Tsujihata M, Takamori M, Nagataki S. [A case of myxedema associated with cerebellar ataxia and various neurological findings]. Nihon Naika Gakkai Zasshi. 1982 Jul 10;71(7):995–998. [PubMed]
  • Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology. 1997 Oct;49(4):1026–1030. [PubMed]
  • Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol. 1999 Apr;56(4):405–408. [PubMed]
  • Porta-Etessam J, Berbel A, Martínez-Salio A, Benito-León J, Pitarch D, Molina JA, Bermejo F. Degeneración cerebelosa paraneoplásica con síndrome pancerebeloso asimétrico. Rev Neurol. 1998 Jun;26(154):1015–1017. [PubMed]
  • Roy M, Stip E, Black D, Lew V, Langlois R. Dégénérescence cérébelleuse secondaire à une intoxication aiguë au lithium. Rev Neurol (Paris) 1998 Jul;154(6-7):546–548. [PubMed]
  • Honnorat J, Trouillas P, Thivolet C, Aguera M, Belin MF. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol. 1995 May;52(5):462–468. [PubMed]
  • Tanaka M, Kawarabayashi T, Okamoto K, Morimatsu M, Hirai S. [Reduction of cerebellar blood flow and metabolic rate of oxygen in a case of hypothyroidism presenting cerebellar ataxia]. Rinsho Shinkeigaku. 1987 Oct;27(10):1262–1265. [PubMed]
  • Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996 Jul 11;335(2):99–107. [PubMed]
  • Dropcho EJ. Neurologic paraneoplastic syndromes. J Neurol Sci. 1998 Jan 8;153(2):264–278. [PubMed]
  • Manto MU, Rondeaux P, Jacquy J, Hildebrand JG. Subacute pancerebellar syndrome associated with systemic lupus erythematosus. Clin Neurol Neurosurg. 1996 May;98(2):157–160. [PubMed]
  • Price TR, Netsky MG. Myxedema and ataxia. Cerebellar alterations and "neural myxedema bodies". Neurology. 1966 Oct;16(10):957–962. [PubMed]
  • BECKER KL, FERGUSON RH, McCONAHEY WM. The connective-tissue diseases and symptoms associated with Hashimoto's thyroiditis. N Engl J Med. 1963 Feb 7;268:277–280. [PubMed]
  • Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology. 1997 Aug;49(2):623–626. [PubMed]
  • Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases. Neurology. 1991 Feb;41(2 ):228–233. [PubMed]
  • Shein M, Apter A, Dickerman Z, Tyano S, Gadoth N. Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain Dev. 1986;8(1):60–64. [PubMed]
  • NICKEL SN, FRAME B. Neurologic manifestations of myxedema. Neurology. 1958 Jul;8(7):511–517. [PubMed]
  • Korczyn AD, Nisipeanu P. Safety profile of copolymer 1: analysis of cumulative experience in the United States and Israel. J Neurol. 1996 Apr;243(4 Suppl 1):S23–S26. [PubMed]
  • Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997 Jan;15(1):62–69. [PubMed]
  • Voltz R, Carpentier AF, Rosenfeld MR, Posner JB, Dalmau J. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Muscle Nerve. 1999 Jan;22(1):119–122. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...